AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Edarkos 1.5mg Injection

Prescription Icon
Prescription Required

Marketer

Elkos Healthcare Pvt Ltd

Salt Composition

Edaravone (1.5mg)

Overview Edarkos 1.5mg Injection

In amyotrophic lateral sclerosis (ALS), a debilitating neuromuscular condition, Edarkos 1.5mg Injection offers therapeutic intervention by slowing disease advancement. This antioxidant medication mitigates nerve cell deterioration, administered intravenously by a medical professional when oral intake is infeasible. Dosage and treatment duration should strictly adhere to physician instructions; missed doses should be taken promptly upon recollection. While headache, bruising, and impaired gait are prevalent side effects, localized injection site reactions (pain, redness, or swelling) are also possible, typically resolving spontaneously. However, persistent or troublesome side effects warrant immediate medical consultation. Seek immediate medical attention for allergic responses including itching, facial or lingual swelling.

Uses of Edarkos 1.5mg Injection

Lou Gehrig's disease

Major Benefits of Edarkos 1.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Edarkos 1.5mg Injection:

  • Bruise
  • Walking difficulties
  • Headache
  • Injection site reactions (pain, swelling, redness)

How to use Edarkos 1.5mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Edarkos 1.5mg Injection works:

Edarkos 1.5mg Injection offers antioxidant, neuroprotective, and nootropic benefits. Its mechanism involves mitigating neuronal damage from free radicals, thereby delaying ALS symptom onset. This effect stems from its ability to restore equilibrium between antioxidants and free radicals, reducing oxidative stress within the brain.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Edarkos 1.5mg Injection may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Administering Edarkos 1.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Edarkos 1.5mg Injection with breastfeeding is currently lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

Edarkos 1.5mg Injection's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Edarkos 1.5mg Injection's use in individuals with renal impairment. Physician consultation is advised.

LiverLiverCAUTION

The administration of Edarkos 1.5mg Injection requires careful consideration in individuals with significant hepatic impairment. Dosage modification of Edarkos 1.5mg Injection might be necessary. Physician consultation is advised. Data concerning Edarkos 1.5mg Injection use in such patients is limited. Dosage changes are not suggested for patients exhibiting mild or moderate liver dysfunction.

What if you forget to take Edarkos 1.5mg Injection :

NA

Facts to Know About Edarkos 1.5mg Injection

LabelValue
Chemical Type Pyrazolone Derivatives
Developing Habits No.
Treatment Category Neuroscience of the Central Nervous System
Actions Cognitive enhancer

FAQs on Edarkos 1.5mg Injection

Edarkos 1.5mg Injection may cause confusion, headache, and gait disturbances. Less frequent side effects include skin rash and itching, respiratory symptoms such as shortness of breath, chest tightness, wheezing, and cough (particularly in asthmatics), and fungal infections.
Administered by a healthcare professional in a medical setting, Edarkos 1.5mg Injection is a solution injected intravenously over one hour. Initially, it's given daily for the first 14 days of a 28-day cycle. Subsequent cycles involve daily injections for the first 10 days of a 28-day cycle. Dosage frequency is determined by your doctor based on your individual response.
Edarkos 1.5mg Injection treats amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease causing muscle weakness and atrophy due to nerve cell deterioration. It works by slowing the progression of ALS-related nerve damage.
Tell your doctor or pharmacist if you're allergic to edaravone, sodium bisulfite, other medications, or any Edarkos 1.5mg Injection ingredient. Before starting edaravone, inform your doctor about all other medications, vitamins, and supplements you're taking or plan to take; they may adjust your dosages or monitor you closely. Also, tell your doctor about any history of asthma, and if you're pregnant, planning to become pregnant, or breastfeeding. Contact your doctor immediately if you become pregnant during treatment.
While ALS prevention remains unproven due to a lack of supporting studies, mitigating risk factors may lessen the likelihood of developing the disease. These factors include smoking, and exposure to pesticides and insecticides. Military service has also been linked to a higher ALS risk.
People of Caucasian, non-Hispanic descent are most frequently diagnosed with ALS. Between 5% and 10% of cases are familial, inherited from parents. Onset can occur at any age, though symptoms typically appear between ages 55 and 75. Men are slightly more prone than women, a difference that lessens with age. Research also indicates that military veterans may have a 1.5 to 2 times higher risk due to potential wartime toxin exposure.
Exposure to toxins from warfare or intense physical exertion may contribute to a higher ALS risk among veterans and athletes.
ALS often begins with subtle muscle problems: twitches in limbs or tongue, cramps, stiffness, and weakness in an arm, leg, neck, or diaphragm. Speech may become slurred or nasal, and swallowing difficult. The initial symptom might be hand weakness hindering simple actions like buttoning a shirt. Alternatively, leg weakness can manifest as clumsiness, tripping, or stumbling.
Edarkos 1.5mg Injection
393
MRP 479
17% off